Stage IV Inflammatory Breast Carcinoma (DBCOND0084502)

Identifiers

Synonyms

Stage IV Breast Inflammatory Carcinoma

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT05041101	Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer	AT-001 Eribulin Grapiprant	treatment	1 / 2	terminated
NCT03202316	Atezolizumab, Cobimetinib, and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer	Atezolizumab Cobimetinib Eribulin	treatment	2	active_not_recruiting
NCT02411656	Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy	Pembrolizumab	treatment	2	active_not_recruiting
NCT02892734	Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer	Ipilimumab Nivolumab	treatment	2	terminated
NCT02658812	Talimogene Laherparepvec in Treating Patients With Recurrent Breast Cancer That Cannot Be Removed by Surgery	Talimogene laherparepvec	treatment	2	terminated